252 related articles for article (PubMed ID: 21105276)
1. Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment.
Perez-Iglesias R; Mata I; Amado JA; Berja A; Garcia-Unzueta MT; Martínez García O; Arranz MJ; Vazquez-Barquero JL; Crespo-Facorro B
J Clin Psychopharmacol; 2010 Dec; 30(6):661-6. PubMed ID: 21105276
[TBL] [Abstract][Full Text] [Related]
2. Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia.
Song X; Pang L; Feng Y; Fan X; Li X; Zhang W; Gao J; Zhang J; Nemani K; Zhang H; Lv L
Behav Brain Funct; 2014 Oct; 10(1):35. PubMed ID: 25278160
[TBL] [Abstract][Full Text] [Related]
3. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.
Brandl EJ; Frydrychowicz C; Tiwari AK; Lett TA; Kitzrow W; Büttner S; Ehrlich S; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ; Puls I
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):134-41. PubMed ID: 22426215
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting.
Gregoor JG; van der Weide J; Loovers HM; van Megen HJ; Egberts TC; Heerdink ER
Pharmacogenomics; 2011 Jun; 12(6):919-23. PubMed ID: 21510767
[TBL] [Abstract][Full Text] [Related]
5. Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study.
Shing EC; Tiwari AK; Brandl EJ; Zai CC; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
Neuropsychobiology; 2014; 69(1):59-63. PubMed ID: 24481458
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
Gregoor JG; van der Weide J; Mulder H; Cohen D; van Megen HJ; Egberts AC; Heerdink ER
J Clin Psychopharmacol; 2009 Feb; 29(1):21-5. PubMed ID: 19142102
[TBL] [Abstract][Full Text] [Related]
7. Associations between obesity candidate gene polymorphisms (fat mass and obesity-associated (FTO), melanocortin-4 receptor (MC4R), leptin (LEP) and leptin receptor (LEPR)) and dietary intake in pregnant women.
Martins MC; Trujillo J; Freitas-Vilela AA; Farias DR; Rosado EL; Struchiner CJ; Kac G
Br J Nutr; 2018 Aug; 120(4):454-463. PubMed ID: 29893663
[TBL] [Abstract][Full Text] [Related]
8. Genetic association between antipsychotic induced weight gain and FTO gene in a Sri Lankan population.
de Silva VA; Muneeswaran K; Ratnatunga SS; Ranwala I; Gamage S; Hanwella R; Wijeyaratne CN; Chandrasekharan NV
Ceylon Med J; 2019 Jun; 64(2):40-45. PubMed ID: 31455065
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis.
Templeman LA; Reynolds GP; Arranz B; San L
Pharmacogenet Genomics; 2005 Apr; 15(4):195-200. PubMed ID: 15864111
[TBL] [Abstract][Full Text] [Related]
10. Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.
Nurmi EL; Spilman SL; Whelan F; Scahill LL; Aman MG; McDougle CJ; Arnold LE; Handen B; Johnson C; Sukhodolsky DG; Posey DJ; Lecavalier L; Stigler KA; Ritz L; Tierney E; Vitiello B; McCracken JT;
Transl Psychiatry; 2013 Jun; 3(6):e274. PubMed ID: 23799528
[TBL] [Abstract][Full Text] [Related]
11. Fat Mass and Obesity-Related Gene Variants rs9939609 and rs7185735 are Associated with Second-Generation Antipsychotic-Induced Weight Gain.
Schröder C; Czerwensky F; Leucht S; Steimer W
Pharmacopsychiatry; 2019 Jan; 52(1):16-23. PubMed ID: 29334686
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications.
Lee AK; Bishop JR
Pharmacogenomics; 2011 Jul; 12(7):999-1016. PubMed ID: 21787190
[TBL] [Abstract][Full Text] [Related]
13. Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication.
Gregoor JG; Mulder H; Cohen D; van Megen HJ; Egberts TC; Heerdink ER; van der Weide J
J Clin Psychopharmacol; 2010 Dec; 30(6):702-5. PubMed ID: 21105285
[TBL] [Abstract][Full Text] [Related]
14. The FTO rs9939609 and LEPR rs1137101 mothers-newborns gene polymorphisms and maternal fat mass index effects on anthropometric characteristics in newborns: A cross-sectional study on mothers-newborns gene polymorphisms-The FTO-LEPR Study (STROBE-compliant article).
Mărginean C; Mărginean CO; Iancu M; Meliţ LE; Tripon F; Bănescu C
Medicine (Baltimore); 2016 Dec; 95(49):e5551. PubMed ID: 27930556
[TBL] [Abstract][Full Text] [Related]
15. The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients.
Reynolds GP; Yevtushenko OO; Gordon S; Arranz B; San L; Cooper SJ
Int J Neuropsychopharmacol; 2013 Jul; 16(6):1421-5. PubMed ID: 23236985
[TBL] [Abstract][Full Text] [Related]
16. Association between LEPR, FTO, MC4R, and PPARG-2 polymorphisms with obesity traits and metabolic phenotypes in school-aged children.
Almeida SM; Furtado JM; Mascarenhas P; Ferraz ME; Ferreira JC; Monteiro MP; Vilanova M; Ferraz FP
Endocrine; 2018 Jun; 60(3):466-478. PubMed ID: 29679223
[TBL] [Abstract][Full Text] [Related]
17. Aerobic fitness does not modify the effect of FTO variation on body composition traits.
Huuskonen A; Lappalainen J; Oksala N; Santtila M; Häkkinen K; Kyröläinen H; Atalay M
PLoS One; 2012; 7(12):e51635. PubMed ID: 23284729
[TBL] [Abstract][Full Text] [Related]
18. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
Opgen-Rhein C; Brandl EJ; Müller DJ; Neuhaus AH; Tiwari AK; Sander T; Dettling M
Pharmacogenomics; 2010 Jun; 11(6):773-80. PubMed ID: 20504252
[TBL] [Abstract][Full Text] [Related]
19. Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics.
Roffeei SN; Mohamed Z; Reynolds GP; Said MA; Hatim A; Mohamed EH; Aida SA; Zainal NZ
Pharmacogenomics; 2014 Mar; 15(4):477-85. PubMed ID: 24624915
[TBL] [Abstract][Full Text] [Related]
20. A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort).
Ter Hark SE; Jamain S; Schijven D; Lin BD; Bakker MK; Boland-Auge A; Deleuze JF; Troudet R; Malhotra AK; Gülöksüz S; Vinkers CH; Ebdrup BH; Kahn RS; Leboyer M; Luykx JJ
J Psychopharmacol; 2020 May; 34(5):524-531. PubMed ID: 32126890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
